Sectoral Asset Management Inc Crispr Therapeutics Ag Transaction History

Sectoral Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $33,719 - $57,587	-780 Reduced 23.85%	2,490 $151,000
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $2.4 Million - $4.56 Million	-21,700 Reduced 86.9%	3,270 $398,000
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $1.99 Million - $4.33 Million	24,970 New	24,970 $3.82 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $8.98 Million - $11.5 Million	-114,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $3.99 Million - $7.88 Million	103,650 Added 964.19%	114,400 $8.41 Million
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $362,060 - $672,197	10,750 New	10,750 $456,000

486

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.